Evidence map›Paper›PMID 38929865›Full record

ReviewJournal of personalized medicine2024

Unveiling the Hidden Perils: A Comprehensive Review of Fungal Infections in Inflatable Penile Prosthesis Surgery.

Anastasios Natsos, Vasileios Tatanis, Alexandra Lekkou, Stavros Kontogiannis, Athanasios Vagionis, Theodoros Spinos, Angelis Peteinaris, Mohammed Obaidat, Konstantinos Pagonis, Panagiotis Kallidonis and 2 more

Abstract readReview
In one paragraph

Review in Journal of personalized medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. An update on penile prostheses: a narrative review.Asian journal of andrology · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anastasios NatsosDepartment of Urology, University of Patras Hospital, 26504 Patras, Greece.ORCID 0000-0002-5845-7420
Vasileios TatanisDepartment of Urology, University of Patras Hospital, 26504 Patras, Greece.ORCID 0000-0002-8584-3888
Alexandra LekkouDepartment of Infectious Diseases, University General Hospital of Patras, 26504 Patras, Greece.
Stavros KontogiannisDepartment of Urology, University of Patras Hospital, 26504 Patras, Greece.
Athanasios VagionisDepartment of Urology, University of Patras Hospital, 26504 Patras, Greece.
Theodoros SpinosDepartment of Urology, University of Patras Hospital, 26504 Patras, Greece.ORCID 0000-0003-2547-8329
Angelis PeteinarisDepartment of Urology, University of Patras Hospital, 26504 Patras, Greece.ORCID 0000-0002-0427-4506
Mohammed ObaidatDepartment of Urology, University of Patras Hospital, 26504 Patras, Greece.ORCID 0000-0001-7021-7510
Konstantinos PagonisDepartment of Urology, University of Patras Hospital, 26504 Patras, Greece.ORCID 0000-0003-1657-9689
Panagiotis KallidonisDepartment of Urology, University of Patras Hospital, 26504 Patras, Greece.
Evangelos LiatsikosDepartment of Urology, University of Patras Hospital, 26504 Patras, Greece.
Petros DrettasDepartment of Urology, University of Patras Hospital, 26504 Patras, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflatable penile prosthesis (IPP) surgery is an effective treatment for erectile dysfunction (ED), but infections pose a significant threat to its success. Current guidelines lack antifungal recommendations, despite rising fungal infection rates post-IPP surgery. This review examines epidemiology, risk factors (including diabetes mellitus, immunosuppression, and obesity), and pathogenesis, highlighting the role of biofilm formation in device contamination. Clinical manifestations vary from acute to delayed, with fungal biofilms presenting challenges in diagnosis. Prophylactic strategies, including broad-spectrum antibiotics and antifungals, are crucial, with evidence suggesting a 92% reduction in infections. With fungal infections showing lower salvage rates, management involves culture-guided treatment, irrigation, and oral antibiotics. Future research aims to understand biofilm mechanisms and develop biomaterials to reduce infection rates. Implementing antifungal therapy, along with standard practices like the no-touch technique and antibiotic dips, is crucial in preventing IPP infections.

Indexed as

diabetes mellitusfungal infectionsguidelinespenile implantspenile prosthesissexual dysfunction

Identifiers

PMID38929865
PMCPMC11204475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.